-0.95 | -0.47%
| Price and Volume | |
|---|---|
| Recent Price | 202.40 |
| 52 Week High | 261.98 |
| 52 Week Low | 171.68 |
| Avg. Daily Vol. (Mil) | 0.00 |
| Beta (3 year) | 0.59 |
| Share Related Items | |
| Mkt Cap (Mil) | 406.81 |
| Shares Out (Mil) | 2.01 |
| Float (Mil) | 1.38 |
| Dividend Information | |
| Yield % | 1.00 |
| Annual Dividend | 1.96 |
| Payout Ratio | 16.00 |
| Financial Strength | |
| Quick Ratio | 6.00 |
| Current Ratio | 9.20 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 16.70 |
| Price/Sales | 3.50 |
| Price/Book | 2.88 |
| Price/Cash Flow | 13.00 |
| Per Share Data | |
| Earnings | 12.09 |
| Sales | 57.89 |
| Book Value | 70.25 |
| Cash Flow | 15.55 |
| Business Summary | |
|---|---|
| Atrion Corporation and its subsidiaries design, develop, manufacture, sell and distribute products mainly for the medical and healthcare industry. | |
| General Information | |
| One Allentown Parkway
Allen, TX 75002 |
|
| www.atrioncorp.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 458 | |
| CEO: Mr. David A. Battat | |
| Short Interest | |
| Current Month (Mil) | 0.05 |
| Previous Month (Mil) | 0.06 |
| Short Interest Ratio (Days) | 13.70 |
| Management Effectiveness | |
| Return on Equity | 17.40 |
| Return on Assets | 15.10 |
| Return on Investments | 17.40 |
| Profitability | |
| Gross Margin | 55.80 |
| EBIT Margin | 32.00 |
| Profit Margin | 21.10 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
107.26
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet